Nuveen Asset Management, LLC - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 79 filers reported holding ARCUS BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q2 2024$2,547,995
+6.1%
167,301
+31.5%
0.00%0.0%
Q1 2024$2,401,895
-5.8%
127,219
-4.7%
0.00%0.0%
Q4 2023$2,548,838
-69.4%
133,447
-71.2%
0.00%
-66.7%
Q3 2023$8,327,417
-10.5%
463,923
+1.3%
0.00%0.0%
Q2 2023$9,304,884
+115517.3%
458,143
+3.8%
0.00%0.0%
Q1 2023$8,048
+173.5%
441,241
+210.0%
0.00%
+200.0%
Q4 2022$2,943
-99.9%
142,316
-14.6%
0.00%
-50.0%
Q3 2022$4,360,000
+0.2%
166,675
-2.9%
0.00%0.0%
Q2 2022$4,350,000
-51.3%
171,631
-33.5%
0.00%
-33.3%
Q1 2022$8,932,000
-11.3%
258,002
-0.5%
0.00%0.0%
Q4 2021$10,067,000
-0.5%
259,226
-6.8%
0.00%0.0%
Q3 2021$10,118,000
-13.3%
278,043
-34.6%
0.00%0.0%
Q2 2021$11,673,000
+141.7%
425,074
+147.2%
0.00%
+50.0%
Q1 2021$4,830,000
-9.1%
171,985
-16.0%
0.00%0.0%
Q4 2020$5,316,000
+43.4%
204,789
-5.3%
0.00%
+100.0%
Q3 2020$3,708,000
-46.7%
216,352
-23.1%
0.00%
-66.7%
Q2 2020$6,962,000
+112.4%
281,427
+19.2%
0.00%
+50.0%
Q1 2020$3,278,000
+74.4%
236,120
+26.8%
0.00%
+100.0%
Q4 2019$1,880,000
+47.1%
186,162
+32.5%
0.00%0.0%
Q3 2019$1,278,000
+20.5%
140,455
+5.2%
0.00%
Q2 2019$1,061,000133,4930.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q2 2019
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,842,077$64,233,00017.21%
Octagon Capital Advisors LP 970,164$33,830,0008.33%
Copernicus Capital Management, LLC 17,000$593,0007.18%
EcoR1 Capital, LLC 5,122,359$178,617,0006.21%
BVF INC/IL 3,229,822$112,624,0004.39%
PFM Health Sciences, LP 3,431,010$119,639,0003.52%
Alphabet Inc. 4,100,475$142,984,0003.39%
Boxer Capital, LLC 2,084,883$72,700,0002.54%
SECTORAL ASSET MANAGEMENT INC 739,010$25,769,0002.14%
Parkman Healthcare Partners LLC 236,637$8,252,0002.09%
View complete list of ARCUS BIOSCIENCES INC shareholders